JB

Jay Bipinchandra Trivedi

Active Director Director DIN 11373380
DIN 11373380 First appointment Nov 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jay Bipinchandra Trivedi

Data last updated:

Jay Bipinchandra Trivedi is a Director at Clinitext Solutions Private Limited (since 2025). The company operates in Healthcare.

DIN 11373380
Primary Designation Director
Industry Healthcare
First Appointment 07 Nov 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clinitext Solutions Private Limited U86909GJ2025PTC169337
Director07 Nov 20252025Active

Board colleagues of Jay Bipinchandra Trivedi

NameDINCompanyDesignation
Dipikaben Rakeshbhai Soni11373381Clinitext Solutions Private LimitedDirector

Directorship timeline

Open interactive timeline →
Clinitext Solutions Private Limited
Premium access

Shareholding and investment profile for Jay Bipinchandra Trivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jay Bipinchandra Trivedi

Jay Bipinchandra Trivedi currently holds 1 directorship: Clinitext Solutions Private Limited (Director, since 07 Nov 2025).

Jay Bipinchandra Trivedi was first appointed on 07 Nov 2025 as Director at Clinitext Solutions Private Limited.

The current boards of Jay Bipinchandra Trivedi's companies include Dipikaben Rakeshbhai Soni (Clinitext Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available